Online Adaptive Radiotherapy Cervical Cancer With Reduced Margin for Cervical Cancer
Phase 1
Active, not recruiting
- Conditions
- Uterine Cervical Neoplasm
- Interventions
- Radiation: online adaptive radiotherapy
- First Posted Date
- 2023-05-30
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT05880485
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
68Ga-FAPI-FS PET/CT and PET/MR in Pancreatic Cancer
Early Phase 1
Recruiting
- Conditions
- Pancreatic Cancer
- Interventions
- Diagnostic Test: 68Ga-FAPI-FS PET/CT
- First Posted Date
- 2023-05-25
- Last Posted Date
- 2023-05-25
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT05875753
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
Teaching Neuraxial Ultrasonography With a Virtual Reality Simulator of Spine
Not Applicable
Not yet recruiting
- Conditions
- Neuraxial Ultrasonography
- Interventions
- Other: Teaching with VR spine simulatorOther: Traditional didactic teaching
- First Posted Date
- 2023-05-25
- Last Posted Date
- 2023-05-25
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 46
- Registration Number
- NCT05874609
Choice of the Optimal Treatment Strategies for Mid-low REctal Cancer
Recruiting
- Conditions
- Rectal Neoplasms
- First Posted Date
- 2023-05-23
- Last Posted Date
- 2023-08-28
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 3705
- Registration Number
- NCT05871762
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer
Phase 1
Active, not recruiting
- Conditions
- Endometrial NeoplasmsUterine Cervical Neoplasm
- Interventions
- Radiation: Online adaptive radiotherapy
- First Posted Date
- 2023-05-22
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 17
- Registration Number
- NCT05869123
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture
Not Applicable
Recruiting
- Conditions
- Osteoporotic Fractures
- Interventions
- First Posted Date
- 2023-05-19
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 2478
- Registration Number
- NCT05866029
- Locations
- 🇨🇳
Beijing Friendship Hospital, Capital Medical University, Beijing, China
🇨🇳Beijing Hospital, Beijing, China
🇨🇳Beijing Pinggu Hospital, Beijing, China
Dalpiciclib With Endocrine Therapy for Advanced Breast Cancer After CDK4/6 Inhibitor Failure (DAWNA-FES)
Phase 3
Recruiting
- Conditions
- Advanced Breast Cancer
- Interventions
- Drug: The combination of Dalpiciclib with physician-selected endocrine therapyDrug: Chemotherapy selected by the physician
- First Posted Date
- 2023-05-17
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT05861830
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
Efficacy and Safety of Comprehensive Treatment in Patients with IR-CAD: a Self-controlled Cohort Study
Recruiting
- Conditions
- Coronary Artery DiseaseCoronary Artery StenosisCoronary Artery RestenosisInflammatory DiseaseInflammationCoronary Artery Disease ProgressionInflammation Vascular
- Interventions
- Behavioral: Healthy life styleDrug: Secondary prevention for atherosclerotic coronary artery diseaseDrug: Immunosuppressive therapyDrug: Supportive therapiesProcedure: Coronary revascularization
- First Posted Date
- 2023-05-16
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 39
- Registration Number
- NCT05860400
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
99mTc-HFAPI SPECT/CT in Pulmonary Fibrosis
Not Applicable
Recruiting
- Conditions
- Pulmonary Fibrosis
- Interventions
- Drug: 99mTc-HFAPI
- First Posted Date
- 2023-05-16
- Last Posted Date
- 2023-05-16
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 150
- Registration Number
- NCT05859763
- Locations
- 🇨🇳
Peking union medical college hospital, Beijing, Dongcheng, China
The Efficacy and Safety of Temozolomide in Patients With MPPGL
Phase 2
Completed
- Conditions
- Pheochromocytoma, MetastaticParaganglioma, MalignantPheochromocytoma Malignant
- Interventions
- First Posted Date
- 2023-05-15
- Last Posted Date
- 2023-05-15
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 62
- Registration Number
- NCT05858177
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath